SPECT/CT and PET/CT molecular imaging in medullary thyroid carcinoma. Are we running in the right direction?

SPECT/CT and PET/CT molecular imaging in medullary thyroid carcinoma. Are we running in the right... Eur J Nucl Med Mol Imaging (2017) 44:1692–1694 DOI 10.1007/s00259-017-3757-6 EDITORIAL COMMENTARY SPECT/CT and PET/CT molecular imaging in medullary thyroid carcinoma. Are we running in the right direction? 1 2 1 Anna Margherita Maffione & Francesco Giammarile & Domenico Rubello Received: 6 June 2017 /Accepted: 7 June 2017 /Published online: 22 June 2017 Springer-Verlag GmbH Germany 2017 We have read with interest the paper by Yamaga LYI et al. Recurrent disease may be disclosed during follow-up of entitled B Ga-DOTATATE PET/CT in recurrent medullary MTC patients with persistently elevated/increasing serum Ct thyroid carcinoma: a lesion-by-lesion comparison with In- levels or, more rarely and especially in the case of poorly octreotide SPECT/CT and conventional imaging^ published differentiated and aggressive tumors, with increasing serum in the European Journal of Nuclear Medicine and Molecular carcinoembryonic antigen (CEA) levels. In general, scientific Imaging [1]. It is focused on the comparison between different communities agree that an increase in the serum Ct level diagnostic imaging methods in order to investigate their effec- above 150 pg/mL should prompt additional imaging in order tiveness in localizing recurrent medullary thyroid carcinoma to localize and possibly surgically remove lesions. (MTC). Several parameters have probably biased the above Immunohistochemical http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Nuclear Medicine and Molecular Imaging Springer Journals

SPECT/CT and PET/CT molecular imaging in medullary thyroid carcinoma. Are we running in the right direction?

Loading next page...
 
/lp/springer_journal/spect-ct-and-pet-ct-molecular-imaging-in-medullary-thyroid-carcinoma-X6NyzTD3FC
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag GmbH Germany
Subject
Medicine & Public Health; Nuclear Medicine; Imaging / Radiology; Orthopedics; Cardiology; Oncology
ISSN
1619-7070
eISSN
1619-7089
D.O.I.
10.1007/s00259-017-3757-6
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial